560.50
-0.15%
ICICI Securities Limited
Solara Active Pharma’s (Solara) Q2FY23 performance was below our estimates across all parameters.
Solara Active Pharma Sciences Ltd. average weekly volume is high.
More from Solara Active Pharma Sciences Ltd.
Recommended